Tolerance and Efficacy of D-cycloserine in Drug-Free Schizophrenic Patients

Bart N.M. van Berckel,Ron Hijman,Jan A. van der Linden,H.G.M. Westenberg,Jan M. van Ree,R.S. Kahn

DOI: https://doi.org/10.1016/0920-9964(96)85448-x

IF: 4.662

1996-01-01

Schizophrenia Research

Abstract:The cooperative inhibition of serine transhydroxymethylase (EC 2.1.2.1) in spleen tissue of mice after intraperitoneal injections of various vitamin B6 antimetabolites was studied. The data obtained reveal that pyridoxal azine, when injected alone in a dose of 75 mg/kg of body weight, produced moderate inhibition of serine transhydroxymethylase, but, when injected in the same dose 1 hr prior to d-cycloserine (500 mg/kg of body weight) injection, exerted a slight potentiating effect on the enzyme inhibition produced by d- cycloserine. In similar experiments, pyridoxal monomethylhydrazone in a dose of 7.5 mg/kg of body weight did not inhibit the activity of serine transhydroxymethylase and did not produce a potentiating effect on inhibition of the enzyme by d-cycloserine. 4-Vinylpyridoxal (4-vinyl-4-deformylpyridoxal), injected into mice in a dose of 0.5 to 1.0 mg/kg of body weight, does not decrease the activity of serine transhydroxymethylase in spleen tissue, but when injected 1 hr prior to injective of d-cycloserine or its dimer, it potentiates (unlike pyridoxal monomethylhydrazone) the inhibitory effects of both d-cycloserine and its dimer, producing more extensive and more prolonged inhibition of the enzyme. If d-cycloserine or its dimer is injected into mice in doses of 500 mg/kg of body weight, the potentiating effect of 4-vinylpyridoxal approaches 200–250 per cent or more, depending on the time after the injection of the antimetabolite. Thus, it is of interest to study further the chemotherapeutic action of moderate doses of d-cycloserine or its dimer in combination with 4-vinylpyridoxal.